Boris Kubuschok Selected Research

Proto-Oncogene Proteins p21(ras)

2/2006	Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer.
5/2002	Use of spontaneous Epstein-Barr virus-lymphoblastoid cell lines genetically modified to express tumor antigen as cancer vaccines: mutated p21 ras oncogene in pancreatic carcinoma as a model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Boris Kubuschok Research Topics

Disease

16	Neoplasms (Cancer) 01/2017 - 05/2002
11	Testicular Neoplasms (Testicular Cancer) 07/2013 - 09/2002
6	Pancreatic Neoplasms (Pancreatic Cancer) 12/2012 - 05/2002
6	Breast Neoplasms (Breast Cancer) 09/2011 - 12/2003
4	Lymphoma (Lymphomas) 01/2017 - 11/2005
4	Adenocarcinoma 12/2012 - 04/2004
3	Autoimmune Diseases (Autoimmune Disease) 05/2016 - 01/2015
3	Multiple Myeloma 09/2015 - 07/2007
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 01/2017
2	Chronic Pancreatitis 07/2006 - 04/2004
2	Melanoma (Melanoma, Malignant) 11/2004 - 07/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Systemic Mastocytosis 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017
1	Vasculitis (Vasculitides) 05/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2016
1	Giant Cell Arteritis (Horton Disease) 05/2016
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 09/2015
1	Paraproteinemias (Monoclonal Gammopathy) 01/2015
1	Aneuploidy (Aneuploid) 07/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2009
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 09/2009
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2009
1	Monoclonal Gammopathy of Undetermined Significance 07/2007
1	Human Influenza (Influenza) 09/2006
1	Lymphatic Metastasis 07/2006
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2005
1	Inflammation (Inflammations) 04/2004
1	Hepatocellular Carcinoma (Hepatoma) 09/2002

Drug/Important Bio-Agent (IBA)

18	AntigensIBA 01/2021 - 09/2002
7	Proteins (Proteins, Gene)FDA Link 01/2015 - 11/2004
7	VaccinesIBA 07/2013 - 09/2002
7	EpitopesIBA 09/2011 - 07/2004
6	Peptides (Polypeptides)IBA 09/2011 - 12/2003
5	Neoplasm Antigens (Tumor Antigens)IBA 12/2012 - 05/2002
4	Protein Subunit VaccinesIBA 11/2005 - 12/2003
3	ParaproteinsIBA 09/2015 - 07/2007
3	Complementary DNA (cDNA)IBA 09/2010 - 07/2006
3	Immunoglobulin G (IgG)IBA 09/2009 - 07/2006
3	SCP 1IBA 07/2006 - 09/2002
2	AutoantibodiesIBA 05/2016 - 07/2015
2	Cancer VaccinesIBA 12/2012 - 05/2002
2	Codon (Codons)IBA 12/2012 - 05/2002
2	AntibodiesIBA 09/2011 - 09/2009
2	Proto-Oncogene Proteins p21(ras)IBA 02/2006 - 05/2002
2	TESIBA 11/2005 - 09/2002
2	HLA-DR Antigens (HLA-DR)IBA 11/2004 - 07/2004
1	AutoantigensIBA 01/2021
1	Core Binding Factors (Core-Binding Factor)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2017
1	lamin CIBA 05/2016
1	ProgranulinsIBA 07/2015
1	Type I Tumor Necrosis Factor ReceptorsIBA 07/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2013
1	ISCOMATRIXIBA 07/2011
1	Messenger RNA (mRNA)IBA 09/2010
1	Protein Kinase C betaIBA 09/2009
1	SurvivinIBA 09/2009
1	Immunoglobulin A (IgA)IBA 07/2007
1	Insulin-Like PeptidesIBA 07/2007
1	tripeptidyl-peptidase 2IBA 07/2007
1	KinesinsIBA 07/2007
1	Inosine Monophosphate (IMP)IBA 09/2006
1	Gemcitabine FDA Link 07/2006
1	EnzymesIBA 02/2006
1	Oncogene Proteins (Oncogene Protein)IBA 02/2006
1	Estrogen ReceptorsIBA 02/2006
1	MucinsIBA 10/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2004
1	Phenylalanine (L-Phenylalanine)FDA Link 04/2004
1	HLA-A Antigens (HLA-A)IBA 12/2003
1	HLA-A*02:01 antigenIBA 12/2003

Therapy/Procedure

3	Therapeutics 01/2017 - 09/2010
3	Immunotherapy 07/2006 - 05/2002